EUVIMEDEUVIMED entdecken
Crossref

IL-33 Signaling in Lung Injury

Chang Jing, Xia Yue-Feng, Zhang Ma-Zhong, Zhang Li-Ming

Translational Perioperative and Pain Medicine · 2016

DOI: 10.31480/2330-4871/037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Translational Perioperative and Pain Medicine, 2016. Verfasst von Chang Jing und 3 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interleukin (IL)-33, a member of the IL-1 cytokine super-family, acts as both a traditional cytokine and an intracellular nuclear factor. It is generally released from damaged immune cells and signals through its receptor ST2 in an autocrine and paracrine fashion, plays important roles in type-2 innate immunity, and functions as an "alarmin" or a danger signal for cellular damage or cellular stress. Here, we review recent advances of the role of IL-33 in lung injury and explore its potential significance as an attractive therapeutic target.

Zitieren

APA

Jing, C., Yue-Feng, X., Ma-Zhong, Z., & Li-Ming, Z. (2016). IL-33 Signaling in Lung Injury. Translational Perioperative and Pain Medicine. https://doi.org/10.31480/2330-4871/037

Vancouver

Jing C, Yue-Feng X, Ma-Zhong Z, Li-Ming Z. IL-33 Signaling in Lung Injury. Translational Perioperative and Pain Medicine. 2016. doi:10.31480/2330-4871/037

BibTeX
@article{Jing2016,
  author = {Jing, Chang and Yue-Feng, Xia and Ma-Zhong, Zhang and Li-Ming, Zhang},
  title = {IL-33 Signaling in Lung Injury},
  journal = {Translational Perioperative and Pain Medicine},
  year = {2016},
  doi = {10.31480/2330-4871/037}
}
Kostenlos starten →